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Abstract 
BACKGROUND: Subcorneal pustular dermatosis, also known as Sneddon-Wilkinson disease, can be classified 
as one of the neutrophilic dermatoses together with pyoderma gangrenosum. The development of both SPD and 
PG in the same patient has rarely been reported and may be a strong indicator of IgA dysglobulinemia 
CASE REPORT: We report the case of a 34-year-old woman with a 2-year history of relapsing pustular eruptions 
mainly affecting the abdomen, gluteus region, elbows, and the extremities. Four years after the onset of 
subcorneal pustular dermatosis (SPD), she developed pyoderma gangrenosum (PG) on her right hand. In 
literature, the coexistence of SPD and PG in the same patient has already been described. This co-occurrence 
might indicate a certain predisposition for immune dysregulation.  
CONCLUSION: Although the two NDs are often associated with systemic diseases, these patients should be 
followed up for any malignancy because of the strong association between these disorders. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Subcorneal pustular dermatosis (SPD), also 
known as Sneddon-Wilkinson disease, can be 
classified as one of the neutrophilic dermatoses (NDs) 
together with pyoderma gangrenosum (PG). The 
development of both SPD and PG in the same patient 
has rarely been reported and may be a strong 
indicator of IgA dysglobulinemia [1].  
We describe the case of a patient exhibiting 
SPD lesions associated after two years’ duration with 
typical PG. 
 
Case report  
 
A 34-year-old woman was admitted to our 
hospital in 2015 with 2 years-history of relapsing 
pustular eruptions mainly affecting the abdomen, 
gluteus region, elbows, and the extremities (Figure 1). 
Clinical examination showed multiple small painful 
flaccid pustules varying in size from 0.5-2 cm that 
tended to coalesce to form an annular or circinate 
pattern and superficial crusts on the normal or mildly 
erythematous skin. A skin biopsy specimen showed 
subcorneal neutrophilic infiltrate with occasional 
eosinophils and absence of spongiosis or 
acantholysis. In the dermis, there was a dense 
perivascular infiltrate of neutrophils and occasional 
eosinophils (Figure 2). Direct immunofluorescence 
was negative.  
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Figure 1: Subcorneal pustular dermatosis. Small flaccid pustules 
varying in size from 0.5-2 cm that tended to coalesce to form 
annular or circinate pattern 
 
These findings were consistent with SPD 
diagnosis. Dapsone was introduced at a dose of 100 
mg/daily resulting in gradual improvement of SPD with 
few residual scarring. She remained on dapsone for 
20 months with almost complete remission of the 
neutrophilic disease.  
 
Figure 2: SPD histological examination: subcorneal pustule below 
the stratum corneum containing mainly neutrophils 
In 2017, the patient developed on the right 
hand an area of painful, rapidly enlarging, ulceration 
(Figure 3). Clinical examination showed a 2.5 cm 
diameter-ulceration with violaceous borders and 
surrounding erythema. Similar lesions were also 
present on the lower extremities.  
 
Figure 3: Pyoderma gangrenosum. An area of ulceration with 
violaceous borders and surrounding erythema 
 
A skin biopsy found a mixed inflammatory 
infiltrate of neutrophils and lymphocytes, extending 
into the panniculus (Figure 4).  
 
Figure 4: PG histological examination: an intensive mixed 
inflammatory infiltrate including mainly neutrophils associated with 
vessel destruction and necrosis of the epithelium 
 
Direct immunofluorescence was negative. 
Clinical and histopathologic features ware compatible 
with PG diagnosis, according to Delphi Consensus 
criterion [2]. Laboratory investigations showed an 
increased white cell count (11,000/mm
3
) with a normal 
differential. Erythrocyte sedimentation rate (ESR) and 
C-reactive protein (CRP) were elevated (ESR: 20 mm; 
CRP: 0.72 mg/dL). The blood chemistry, liver function 
and renal function tests were within the normal limit. 
Abdominal and pelvic ultrasound and computed 
tomography were normal. A gastroenterological visit 
excluded the presence of inflammatory bowel disease. 
The patient did not respond to topical and oral 
corticosteroids (prednisone 50 mg/daily for a month); 
cyclosporine was introduced at a dosage of 150 
mg/daily (2 mg/kg) in association with tacrolimus 0.1% 
ointment, thus resulting in gradual improvement of 
PG, while SPD remained in remission [3]. 
 
 Ferrillo et al. A Case of the Co-Existence of Subcorneal Pustular Dermatosis 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Jul 20; 6(7):1271-1274.                                                                                                                                                   1273 
 
Discussion 
 
NDs are a group of heterogeneous skin 
diseases, with common features and a common 
histopathologic characterised by polymorphonuclear 
leukocyte inﬁltrates at various levels within the 
epidermis, dermis, or panniculus [4] (Table 1). 
Table 1: NDs classification 
 
NEUTROPHILIC DERMATOSIS [4]
 
 
Superficial (epidermal) En plaque (dermal) Deep (dermal and hypoderma) 
Subcorneal pustular 
dermatosis 
 
Sweet’s syndrome Pyoderma gangrenosum 
IgA pemphigus Neutrophilic eccrine 
hidratenitis 
Neutrophilic panniculitis 
Bullous neutrophilic 
dermatoses 
 
Erythema elavatum diutinum Aseptic abscesses 
Other pustuloses Neutrophilic rheumatoid 
dermatitis 
- 
- Granulomatous pyoderma 
gangrenosum 
- 
 
SPD is a rare chronic and relapsing skin 
disease, characterised by symmetrical sterile pustular 
eruption typically involving the flexural sites of the 
trunk and proximal limbs [1]. Although it is typically 
seen in women over the age of 40 years, there have 
been a few cases found in children [4] [5]. The 
etiopathogenesis of SPD remains unknown [6]. A 
trigger for aberrant neutrophil chemotaxis in SPD has 
not been identiﬁed. Faulty immune mechanisms and 
genetic susceptibility have been proposed, but no 
widely accepted hypothesis has been substantiated 
[3]. PG is a neutrophilic, non-infective skin disorder 
characterised by pustules or nodules, in which sterile 
destructive inflammatory process leads to necrotic 
cutaneous ulceration with violaceous borders and 
central necrosis. Lesions are mainly localised on the 
lower legs, especially on pretibial area [7] [8].  
In our patient, the SPD preceded the PG 
onset by 2 years. In literature, the coexistence of SPD 
and PG in the same patient has been described 
previously in 12 patients (Table 2) [1]. This co-
occurrence might indicate a certain predisposition for 
immune dysregulation. Although the neutrophilic 
accumulation appears to be the hallmark of 
neutrophilic disorders, the exact pathophysiology is 
still unknown. Probably, it is implicated the production 
from T cells activated by polymorphonuclear cells of 
several chemotactic factors, including the pro-
inflammatory cytokines: tumour necrosis factor (TNF)-
a, interleukin (IL)-8 and complement fragment C5a [4] 
[9]. Indeed, a complete remission of clinical 
manifestations, with the off-label use of TNF blocking 
agents in 29-years old man with SPD, refractory to 
first-line therapy, has previously been described [10].  
The two NDs are often associated with 
systemic diseases, including inflammatory bowel 
disease, rheumatoid arthritis, paraproteinemia or 
haematological malignancy, such as monoclonal 
gammopathies, lymphomas and multiple myeloma 
[11].  
Table 2: Articles reporting the coexistence of the two 
neutrophilic diseases published in the literature 
Authors Sex Age Associated disease Therapy Outcome 
Wolff K. 
1971 [12] 
- - IgA gammopathy - - 
Marsden JR, et 
al. 
1986 [15] 
- - IgA gammopathy - - 
Venning VA, et 
al. 1986 [16] 
F 59 IgA gammopathy dapsone remission 
Freire 
Murgueytio P, et 
al. 
1989 [17] 
- - - - - 
Kohl PK, et al. 
1991 [18] 
F 60 IgA gammopathy - - 
Scerri L. 
1994 [14] 
F 89 - CCS, dapsone, 
minocycline 
remission 
Cartier H, et al. 
1995 [19] 
F 54 IgA gammopathy CCS, dapsone remission 
Stone MS, et al. 
1996 [20] 
F 72 Multiple myelomas CCS, dapsone Remission 
T.A.Chave, et al. 
2001 [21] 
M 82 IgA 
paraproteinaemia 
and IgG antiepithelial 
antibodies. 
CCS - 
Puechguiral-
Renaud I, et al. 
2006 [22] 
M 67 IgA and IgG 
gammopathy 
CCS - 
Ahmad K, et al. 
2009 [1] 
F 57 IgA and IgG 
gammopathy, 
multiple myeloma 
CCS, dapsone, 
tacrolimus, acitretin, 
colchicine, 
clofazimine, nbUVB 
cyclosporin, 
cyclophosphamide 
Remission 
Audemard A, et 
al. 2012 [23] 
M 82 Spleen abscess CCS Remission 
 
It is of interest that this diseases combination 
has been reported in the presence of an IgA 
monoclonal gammopathy [12]. However, in 2006 a 
case of a 67-year-old man, affected by both PG and 
SPD simultaneously, who developed a biclonal benign 
IgA and IgG kappa gammopathy have been reported 
[13]. Furthermore, Ahmad et al. described the case of 
a 57-year-old woman, with a 5-year history of PG 
before she developed SPD, associated with biclonal 
IgA and IgG gammopathy, that 12 years later, 
developed myeloma [1]. In our patient, no evidence of 
myeloma or myeloproliferative disorders has been 
found. Although PG and SPD may occur without the 
association of an underlying malignancy as in our 
case¸ these patients should be followed up for any 
malignancy because of the strong association 
between these disorders [14]. 
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